OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Addiction as a brain disease revised: why it still matters, and the need for consilience
Markus Heilig, James MacKillop, Diana Martínez, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 10, pp. 1715-1723
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

A neuromarker for drug and food craving distinguishes drug users from non-users
Leonie Koban, Tor D. Wager, Hedy Kober
Nature Neuroscience (2022) Vol. 26, Iss. 2, pp. 316-325
Open Access | Times Cited: 86

A contextualized reinforcer pathology approach to addiction
Samuel F. Acuff, James MacKillop, James G. Murphy
Nature Reviews Psychology (2023) Vol. 2, Iss. 5, pp. 309-323
Open Access | Times Cited: 56

Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders
Andrea C. King, Andrew M. Fischer, John F. Cursio, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 2, pp. 187-197
Closed Access | Times Cited: 3

Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Luis Antonio Díaz, Daniel König, Sabine Weber, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2

A Fresh Look at the Allostasis Theory of Addiction
Markus Heilig
American Journal of Psychiatry (2025) Vol. 182, Iss. 2, pp. 142-144
Closed Access | Times Cited: 1

The protective effect of operant social reward on cocaine self-administration, choice, and relapse is dependent on delay and effort for the social reward
Marco Vènniro, Leigh V. Panlilio, David H. Epstein, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 13, pp. 2350-2357
Open Access | Times Cited: 80

Dose–Response Relationships between Levels of Alcohol Use and Risks of Mortality or Disease, for All People, by Age, Sex, and Specific Risk Factors
Jürgen Rehm, Pol Rovira, Laura Llamosas‐Falcón, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2652-2652
Open Access | Times Cited: 71

Is addiction a brain disease? A plea for agnosticism and heterogeneity
Hanna Pickard
Psychopharmacology (2021) Vol. 239, Iss. 4, pp. 993-1007
Closed Access | Times Cited: 61

Evaluating the Brain Disease Model of Addiction
Nick Heather, Matt Field, Antony C. Moss, et al.
Routledge eBooks (2022)
Open Access | Times Cited: 56

Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice
Rani Richardson, Agnieszka Sulima, Kenner C. Rice, et al.
Neuropharmacology (2023) Vol. 238, pp. 109643-109643
Open Access | Times Cited: 23

Internet Addiction and Its Associated Factors Among African High School and University Students: Systematic Review and Meta-Analysis
Edgeit Abebe Zewde, Tadesse Tolossa, Sofonyas Abebaw Tiruneh, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 29

Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies
Mehdi Farokhnia, Christopher T. Rentsch, Vicky Chuong, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4642-4652
Open Access | Times Cited: 29

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism
Kevin Domanegg, Wolfgang H. Sommer, Marcus W. Meinhardt
Cells (2023) Vol. 12, Iss. 6, pp. 963-963
Open Access | Times Cited: 18

Should we promote alcohol problems as a continuum? Implications for policy and practice
James Morris, Cassandra L. Boness, Katie Witkiewitz
Drugs Education Prevention and Policy (2023) Vol. 31, Iss. 2, pp. 271-281
Closed Access | Times Cited: 17

New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease
Luis Antonio Díaz, Gerald Scott Winder, Lorenzo Leggio, et al.
Hepatology (2023)
Closed Access | Times Cited: 17

The labels and models used to describe problematic substance use impact discrete elements of stigma: A registered report.
Charlotte R. Pennington, Rebecca L. Monk, Derek Heim, et al.
Psychology of Addictive Behaviors (2023)
Open Access | Times Cited: 16

Heterogeneity in choice models of addiction: the role of context
Samuel F. Acuff, Justin C. Strickland, Kirsten E. Smith, et al.
Psychopharmacology (2024) Vol. 241, Iss. 9, pp. 1757-1769
Closed Access | Times Cited: 7

Novel medications for problematic alcohol use
Markus Heilig, Katie Witkiewitz, Lara A. Ray, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 6

IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
Nicolaus Bruns, Elizabeth H. Tressler, Leandro F. Vendruscolo, et al.
Pharmacological Research (2024) Vol. 207, pp. 107312-107312
Open Access | Times Cited: 6

Identification of risk variants and cross-disorder pleiotropy through multi-ancestry genome-wide analysis of alcohol use disorder
Romain Icick, Alexey Shadrin, Børge Holen, et al.
Nature Mental Health (2025)
Closed Access

EVALUATION OF THE THERAPEUTIC EFFECTS OF SALVIA ROSMARINUS ESSENTIAL OIL ON NERVOUS SYSTEM DISORDERS
Mălina Visternicu, Viorica Rarinca, Vasile Burlui, et al.
Journal of Experimental and Molecular Biology (2025)
Open Access

Combined pharmacological and psychosocial interventions for alcohol use disorder
Silvia Minozzi, Giusy Rita Maria La Rosa, Francesco Salis, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access

Page 1 - Next Page

Scroll to top